Prescription drug · ANDA
Travoprost Ophthalmic Solution NDC 68462-943
Travoprost .04 mg/mL · Solution/ drops · Ophthalmic · GLENMARK PHARMACEUTICALS INC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68462-943-03 | 6846209430368462094303 | 1 BOTTLE in 1 CARTON (68462-943-03) / 2.5 mL in 1 BOTTLEMarketed from Sep 30, 2024 | |
| 68462-943-05 | 6846209430568462094305 | 1 BOTTLE in 1 CARTON (68462-943-05) / 5 mL in 1 BOTTLEMarketed from Sep 30, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Travoprost Ophthalmic Solution
- Generic name (nonproprietary)
- travoprost ophthalmic solution
- Active ingredients
- Travoprost — .04 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- GLENMARK PHARMACEUTICALS INCNDC labeler code 68462
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218159
- Marketing start
- Listing expires
- Other FDA classes
- Prostaglandins (Chemical structure)
- Identifiers
- Product ID 68462-943_23bf6ec3-65b0-4e62-9531-81d2cd742f2cSPL ID 23bf6ec3-65b0-4e62-9531-81d2cd742f2cSPL set ID 2b64a309-c7c1-4f12-9c1e-99fa8310612cRxCUI 284008UNII WJ68R08KX9UPC 0368462943038, 0368462943052
- Pharmacologic class
- Prostaglandin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468462094303followed by a unit qualifier and the quantityPackage 68462-0943-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Travoprost ophthalmic solution (ionic buffered solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Travoprost ophthalmic solution (ionic buffered solution) is a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 68462-943
- What is NDC 68462-943?
- 68462-943 is the product NDC for Travoprost Ophthalmic Solution, Travoprost .04 mg/mL solution/ drops, listed with the FDA by GLENMARK PHARMACEUTICALS INC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Travoprost Ophthalmic Solution.
- What is the active ingredient?
- Travoprost.
- Who is the labeler?
- GLENMARK PHARMACEUTICALS INC, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Travoprost Ophthalmic Solution?
- 4 other product NDCs are listed under this name. See all Travoprost Ophthalmic Solution NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Travoprost Ophthalmic Solution products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Travoprost ophthalmic solutiontravoprost ophthalmic | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | Alembic Pharmaceuticals Limited | 46708-625 | 46708-0625-0246708-0625-05 |
| Travoprost ophthalmic solutiontravoprost ophthalmic | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | Alembic Pharmaceuticals Inc. | 62332-625 | 62332-0625-0262332-0625-05 |
| Travoprost Ophthalmic Solution | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | Gland Pharma Limited | 68083-601 | 68083-0601-01 |
| Travoprost Ophthalmic Solution | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | Gland Pharma Limited | 68083-602 | 68083-0602-01 |
Other NDCs under ANDA 218159
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Travoprost Ophthalmic Solution | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | Gland Pharma Limited | 68083-601 |
| Travoprost Ophthalmic Solution | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | Gland Pharma Limited | 68083-602 |
| Travoprost Ophthalmic Solutontravoprost | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | Sagent Pharmaceuticals | 25021-002 |